A potential role for GPR55 in gastrointestinal functions

Current Opinion in Pharmacology

Volumn 12, Issue 6, 2012, Pages 653-658

  Schicho, Rudolf ^a   Storr, Martin ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABIDIOL; CANNABINOID; CANNABINOID RECEPTOR; G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHATIDYLINOSITOL; O 1602; PHOSPHATIDYLINOSITOL; PROTEIN GPR55; UNCLASSIFIED DRUG;

ARTICLE; COLITIS; DRUG MECHANISM; FOOD INTAKE; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL PAIN; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INTESTINAL SECRETION; INTESTINE MOTILITY; MECHANORECEPTOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; VOMITING;

EID: 84870563609     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.09.009     Document Type: Review

References (58)

1. 2 Pharmacol Rev 62 2010 588 631
2. M. Sawzdargo, T. Nguyen, D.K. Lee, K.R. Lynch, R. Cheng, H.H. Heng, S.R. George, and B.F. O'Dowd Identification and cloning of three novel human G protein-coupled receptor genes GPR52, ΨGPR53 and GPR55: GPR55 is extensively expressed in human brain Brain Res Mol Brain Res 64 1999 193 198
3. D. Baker, G. Pryce, W.L. Davies, and C.R. Hiley In silico patent searching reveals a new cannabinoid receptor Trends Pharmacol Sci 27 2006 1 4
4. F. Petitet, M. Donlan, and A. Michel GPR55 as a new cannabinoid receptor: still a long way to prove it Chem Biol Drug Des 67 2006 252 253
5. R. Schicho, and M. Storr Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases Can J Gastroenterol 25 2011 377 383
6. R. Fredriksson, M.C. Lagerström, L.G. Lundin, and H.B. Schiöth The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints Mol Pharmacol 63 2003 1256 1272
7. D. McHugh, S.S. Hu, N. Rimmerman, A. Juknat, Z. Vogel, J.M. Walker, and H.B. Bradshaw N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor BMC Neurosci 11 2010 44
8. 9-THC and N-arachidonyl glycine are full agonists at GPR18 and cause migration in the human endometrial cell line, HEC-1B Br J Pharmacol 165 2012 2414 2424
9. S. Oka, R. Ota, M. Shima, A. Yamashita, and T. Sugiura GPR35 is a novel lysophosphatidic acid receptor Biochem Biophys Res Commun 395 2010 232 237
10. K. Noguchi, S. Ishii, and T. Shimizu Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family J Biol Chem 278 2003 25600 25606
11. K. Kotarsky, A. Boketoft, J. Bristulf, N.E. Nilsson, A. Norberg, S. Hansson, C. Owman, R. Sillard, L.M. Leeb-Lundberg, and B. Olde Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes J Pharmacol Exp Ther 318 2006 619 628
12. E. Ryberg, N. Larsson, S. Sjögren, S. Hjorth, N.O. Hermansson, J. Leonova, T. Elebring, K. Nilsson, T. Drmota, and P.J. Greasley The orphan receptor GPR55 is a novel cannabinoid receptor Br J Pharmacol 152 2007 1092 1101
13. H. Yin, A. Chu, W. Li, B. Wang, F. Shelton, F. Otero, D.G. Nguyen, J.S. Caldwell, and Y.A. Chen Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay J Biol Chem 284 2009 12328 12338
14. S. Oka, T. Toshida, K. Maruyama, K. Nakajima, A. Yamashita, and T. Sugiura 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55 J Biochem 145 2009 13 20
15. N.A. Balenga, E. Aflaki, J. Kargl, W. Platzer, R. Schröder, S. Blättermann, E. Kostenis, A.J. Brown, A. Heinemann, and M. Waldhoer GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils Cell Res 21 2011 1452 1469
16. J.E. Lauckner, J.B. Jensen, H.Y. Chen, H.C. Lu, B. Hille, and K. Mackie GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current Proc Natl Acad Sci U S A 105 2008 2699 2704
17. 13 and RhoA in PC12 cells PLoS One 6 2011 e24284
18. 1-receptor-triggered repression J Cell Sci 121 2008 1704 1717
19. S.Y. Romero-Zerbo, A. Rafacho, A. Díaz-Arteaga, J. Suárez, I. Quesada, M. Imbernon, R.A. Ross, C. Dieguez, F. Rodríguez de Fonseca, R. Nogueiras, A. Nadal, and F.J. Bermúdez-Silva A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans J Endocrinol 211 2011 177 185
20. L.S. Whyte, E. Ryberg, N.A. Sims, S.A. Ridge, K. Mackie, P.J. Greasley, R.A. Ross, and M.J. Rogers The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo Proc Natl Acad Sci U S A 106 2009 16511 16516
21. C. Andradas, M.M. Caffarel, E. Pérez-Gómez, M. Salazar, M. Lorente, G. Velasco, M. Guzmán, and C. Sánchez The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK Oncogene 30 2011 245 252
22. L. Huang, J.C. Ramirez, G.A. Frampton, L.E. Golden, M.A. Quinn, H.Y. Pae, D. Horvat, L.J. Liang, and S. DeMorrow Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor Lab Invest 91 2011 1007 1017
23. C.M. Henstridge, N.A. Balenga, R. Schröder, J.K. Kargl, W. Platzer, L. Martini, S. Arthur, J. Penman, J.L. Whistler, E. Kostenis, M. Waldhoer, and A.J. Irving GPR55 ligands promote receptor coupling to multiple signalling pathways Br J Pharmacol 160 2010 604 614
24. A.C. Howlett Cannabinoid receptor signaling Handb Exp Pharmacol 168 2005 53 79
25. P.C. Staton, J.P. Hatcher, D.J. Walker, A.D. Morrison, E.M. Shapland, J.P. Hughes, E. Chong, P.K. Mander, P.J. Green, and A. Billinton The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain Pain 139 2008 225 236
26. R.A. Ross The enigmatic pharmacology of GPR55 Trends Pharmacol Sci 30 2009 156 163
27. A.J. Brown, and C. Robin Hiley Is GPR55 an anandamide receptor? Vitam Horm 81 2009 111 137
28. H. Sharir, and M.E. Abood Pharmacological characterization of GPR55, a putative cannabinoid receptor Pharmacol Ther 126 2010 301 313
29. C.M. Henstridge, N.A. Balenga, J. Kargl, C. Andradas, A.J. Brown, A. Irving, C. Sanchez, and M. Waldhoer Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55 Mol Endocrinol 25 2011 1835 1848
30. T. Nevalainen, and A.J. Irving GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity? Curr Top Med Chem 10 2010 799 813
31. J. Fioramonti, and L. Bueno Role of cannabinoid receptors in the control of gastrointestinal motility and perception Expert Rev Gastroenterol Hepatol 2 2008 385 397
32. 2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation Br J Pharmacol 153 2008 263 270
33. 2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats Am J Physiol Gastrointest Liver Physiol 295 2008 G78 G87
34. 2 receptors J Mol Med (Berl) 86 2008 925 936
35. 2) protects against experimental colitis Inflamm Bowel Dis 15 2009 1678 1685
36. M. Duncan, J.S. Davison, and K.A. Sharkey Review article: endocannabinoids and their receptors in the enteric nervous system Aliment Pharmacol Ther 22 2005 667 683
37. X.H. Lin, B. Yuece, Y.Y. Li, Y.J. Feng, J.Y. Feng, L.Y. Yu, K. Li, Y.N. Li, and M. Storr A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents Neurogastroenterol Motil 23 2011 862-e342
38. R. Schicho, M. Bashashati, M. Bawa, D. McHugh, D. Saur, H.M. Hu, A. Zimmer, B. Lutz, K. Mackie, and H.B. Bradshaw The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment Inflamm Bowel Dis 17 2011 1651 1664
39. D.G. Johns, D.J. Behm, D.J. Walker, Z. Ao, E.M. Shapland, D.A. Daniels, M. Riddick, S. Dowell, P.C. Staton, and P. Green The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects Br J Pharmacol 152 2007 825 831
40. A. Díaz-Arteaga, M.J. Vázquez, R. Vazquez-Martínez, M.R. Pulido, J. Suarez, D.A. Velásquez, M. López, R.A. Ross, F.R. de Fonseca, and F.J. Bermudez-Silva The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats Diabetes Obes Metab 2011 10.1111/j.1463-1326. 2011.01515.x
41. G.R. Ross, A. Lichtman, W.L. Dewey, and H.I. Akbarali Evidence for the Putative cannabinoid receptor (GPR55)-mediated inhibitory effects on intestinal contractility in mice Pharmacology 90 2012 55 65
42. 1 neutral antagonists and inverse agonists on gastrointestinal motility in mice Neurogastroenterol Motil 22 2010 787-e223
43. 1) receptors Psychopharmacology (Berl) 143 1999 315 317
44. F. Borrelli, and A.A. Izzo Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance Best Pract Res Clin Endocrinol Metab. 23 2009 33 49
45. F. Rodríguez de Fonseca, M. Navarro, R. Gómez, L. Escuredo, F. Nava, J. Fu, E. Murillo-Rodríguez, A. Giuffrida, J. LoVerme, and S. Gaetani An anorexic lipid mediator regulated by feeding Nature 414 2001 209 212
46. T.C. Kirkham, C.M. Williams, F. Fezza, and V. Di Marzo Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol Br J Pharmacol 136 2002 550 557
47. S. Watanabe, M. Doshi, and T. Hamazaki n-3 polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice Prostaglandins Leukot Essent Fatty Acids 69 2003 51 59
48. I. Matias, T. Bisogno, and V. Di Marzo Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake Int J Obes (Lond) 30 2006 S7 S12
49. H. Ishiguro, E.S. Onaivi, Y. Horiuchi, K. Imai, G. Komaki, T. Ishikawa, M. Suzuki, Y. Watanabe, T. Ando, S. Higuchi, and T. Arinami Functional polymorphism in the GPR55 gene is associated with anorexia nervosa Synapse 65 2011 103 108
50. 2 receptors Science 310 2005 329 332
51. 1 and vanilloid TRPV1 receptors in the ferret Eur. J. Neurosci 25 2007 2773 2782
52. 1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype Am J Physiol Gastrointest Liver Physiol 299 2010 G63 G69
53. J.N. Sengupta, and G.F. Gebhart Characterization of mechanosensitive pelvic nerve afferent fibers innervating the colon of the rat J Neurophysiol 71 1994 2046 2060
54. N. Ozaki, and G.F. Gebhart Characterization of mechanosensitive splanchnic nerve afferent fibers innervating the rat stomach Am J Physiol Gastrointest Liver Physiol 281 2001 G1449 G1459
55. B. Feng, and G.F. Gebhart Characterization of silent afferents in the pelvic and splanchnic innervations of the mouse colorectum Am J Physiol Gastrointest Liver Physiol 300 2011 G170 G180
56. J.N. Sengupta Visceral pain: the neurophysiological mechanism Handb Exp Pharmacol 194 2009 31 74
57. 1 receptors mediate the analgesic effects of cannabinoids on colorectal distension-induced visceral pain in rodents J Neurosci 29 2009 1554 1564
58. E. Kotsikorou, K.E. Madrigal, D.P. Hurst, H. Sharir, D.L. Lynch, S. Heynen-Genel, L.B. Milan, T.D. Chung, H.H. Seltzman, and Y. Bai Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands Biochemistry 50 2011 5633 5647